NOMD
Nomad Foods Limited
NOMD's fundamentals are mixed: it turned 6.9% of its revenue into free cash flow, but earnings per share fell 34%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
NOMD Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
NOMD's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
NOMD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $10.64 | -8.7% |
| Current | 12x | $11.65 | — |
| Fair | 14x | $13.76 | +18% |
| Expensive | 20x | $20.09 | +72% |
Historical ranges are pointers, not guarantees.
NOMD's PE is 12x, but its earnings don't support one, so it isn't a reliable read right now.
NOMD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect NOMD's profitability to weaken, with its earnings and revenue holding steady.
NOMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.98 | -34% |
| Q1 2026 | $1.00 | -35% |
| Q4 2025 | $1.01 | -34% |
| Q3 2025 | $1.43 | +5.1% |
| Q2 2025 | $1.48 | +5.7% |
| Q1 2025 | $1.54 | +25% |
| Q4 2024 | $1.54 | +22% |
| Q3 2024 | $1.36 | +3% |
NOMD's earnings per share have fallen from their peak: $0.98 over the past year, against $1.59 in late 2022.
NOMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $804M | -3.1% |
| Q1 2026 | $794.5M | -5.9% |
| Q4 2025 | $858.8M | -2.6% |
| Q3 2025 | $835.8M | -2.2% |
| Q2 2025 | $829.7M | -0.8% |
| Q1 2025 | $844.4M | -3% |
| Q4 2024 | $881.4M | +4.3% |
| Q3 2024 | $854.9M | +0.8% |
NOMD's revenue grew through 2022 and has held roughly level since: $804M last quarter, down 3.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 12% | +0.5 points |
| Q1 2026 | 7.9% | -1.8 points |
| Q4 2025 | 9.1% | -2.4 points |
| Q3 2025 | 12% | -3.5 points |
| Q2 2025 | 12% | -1.7 points |
| Q1 2025 | 9.7% | +0.5 points |
| Q4 2024 | 12% | +2.8 points |
| Q3 2024 | 16% | +3 points |
NOMD's operating margin was 12% last quarter, up 0.5 points from the same quarter a year ago.
NOMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $31.7M | -44% |
| Q1 2026 | $7.9M | -78% |
| Q4 2025 | $152.9M | -32% |
| Q3 2025 | $35M | -61% |
| Q2 2025 | $56.9M | +$66.7M |
| Q1 2025 | $35.4M | -60% |
| Q4 2024 | $224.5M | +27% |
| Q3 2024 | $90.6M | +0.7% |
NOMD still generates free cash flow, though less than at its 2024 peak: $227M over the past year.
NOMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.3% | -1.9M shares |
| 1 year | -8.2% | -12.5M shares |
| 3 years | -19% | -33.6M shares |
| 5 years | -21% | -37.7M shares |
| Available history | -29% | -56.3M shares |
NOMD has 140M diluted shares, down 8.2% from a year ago, with $133M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $137,232 |
| Q1 2026 | $26.8M |
| Q4 2025 | $49.1M |
| Q3 2025 | $56.7M |
| Q2 2025 | $64.7M |
| Q1 2025 | $54.3M |
| Q4 2024 | $84.2M |
| Q3 2024 | $27M |
NOMD spent $133M buying back its own shares over the past year, down 42% from the year before.
NOMD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.7x | High |
| Q1 2026 | 4.5x | High |
| Q3 2025 | 4.0x | High |
| Q2 2025 | 3.7x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q3 2024 | 3.7x | Elevated |
| Q2 2024 | 3.8x | Elevated |
| Q1 2024 | 3.8x | Elevated |
NOMD's net debt is about 4.7 years of its operating earnings (EBITDA), up from 3.6 years a year ago.
NOMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 64.5 | Neutral |
NOMD's weekly RSI is 54 (neutral) and its Stochastic is 64 (neutral).
NOMD PE vs Consumer Defensive Sector
| Metric | NOMD | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 19x | 39% below |
| PE % | 30 | 18 | 12 pts above |
NOMD is trading at 12x earnings, a 39% discount to the Consumer Defensive sector's median of 19x, though its earnings don't support one.
NOMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.4 | 1.8% above |
| 20 week MA | $11.5 | 1.1% above |
| 50 week MA | $11.2 | 4.2% above |
| 100 week MA | $13.8 | 16% below |
| 200 week MA | $15.7 | 26% below |
NOMD has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 26% below its 200-week average.
NOMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.0 | $25.2 | +15% |
| 2021 | $25.2 | $25.1 | -0.2% |
| 2022 | $25.1 | $17.1 | -32% |
| 2023 | $17.1 | $17.0 | -0.9% |
| 2024 | $17.0 | $16.6 | -2.3% |
| 2025 | $16.6 | $12.5 | -25% |
| 2026 YTD | $12.5 | $11.7 | -6.4% |
NOMD has finished five years in a row lower, and it's down 6.4% so far in 2026.